Vakzine Projekt Management GmbH (VPM)

https://www.vpm-consult.com

VPM was founded in 2002 from Helmholtz-Center for Infection Research. VPM has been active in developing promising biopharmaceutical candidates from academic research. Several products, ranging from small molecules, recombinant proteins up to live vaccines and ATMPs, have successfully been brought into clinical phase I and II trials by VPM and its team members. VPM now offers its experience in translational project management and regulatory liason to its clients in Pharma, Biotech, and Academia. VPM moves developmental products to the clinical stage faster, more cost-efficiently, and with higher success rates. *

	Start	2002-08-01 established
	Group	Deutsche Stiftung Impfstoffforschung
	Industry	vaccine
	Industry 2	CMV dense body technology
	Person	Eisele, Bernd (VPM Vakzine Projekt Management GmbH 201201 CEO)

	Region	Hannover (Hanover)
	Country	Germany
	Street	9 Mellendorfer Str.
	City	30625 Hannover
	Tel	+49-511-169908-0
		Address record changed: 2022-10-02

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2023-12-30

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px

More documents for Deutsche Stiftung Impfstoffforschung

[1] Memo Therapeutics AG. (1/24/23). "Press Release: Memo Therapeutics AG Announces Positive Phase I Data with AntiBKV for Treatment of BKV Infection in Renal Transplant Patients". Schlieren....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

» top